Dr. Offodile joins MSK from the University of Texas MD Anderson Cancer Center in Houston, where he worked as the enterprise executive director for clinical trial transformation and was a member of the plastic surgery department.
In his new role at MSK, Dr. Offodile will oversee strategy and care transformation initiatives “by continuing to develop the core infrastructure, management systems, and processes for enterprise strategy and business development,” according to a news release. He specializes in oncologic reconstruction and will also see patients on a limited basis.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
